Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas

Abstract

The risk of mass enlargement, hormonal, and metabolic impairment over time is globally low. Conservative management seems to be appropriate, but further prospective studies are needed to establish the long-term outcome of such patients, especially for metabolic status, cardiovascular risk profile and their relationship with endocrine function.